Europe

The New Nature Economy series, produced by the World Economic Forum, lays out the risks and opportunities for business. By Akanksha Khatri and Lucy Almond.

Not waiting for nature-positive standards, UK multinational GSK is taking action and a leadership role in the pharma and biotech sector. By Alastair Morton and Ellie Fallon.

Satellite-based tracking of CO2 and methane emissions represent the dawn of a new era for business transparency, says Antoine Rostand, CEO of tracking platform Kayrros.

Preserving and restoring nature is a critical part of the climate solution. Brunswick asks two leaders of this effort to draw on their experience and highlight the role of business.

An introduction to the fourth edition of the Brunswick Social Value Review from the Editors in Chief.

While climate is a well-established concern, mass extinction and ecosystem collapse loom equally large—and businesses are beginning to respond.

After CERAWeek 2023—“the Super Bowl of Energy”—Brunswick caught up with the man at the heart of it.

UK lawmakers fear it, need it and know how to use it, our survey finds. By Bénédicte Earl.

As the European Commission gets set to review the EU’s pharmaceutical legislation, two issues demand particular attention: ensuring supplies of key medicines, especially antibiotics—and encouraging the innovation needed to maintain the therapeutic options available, which…

From a depth of experience that dates back to the hardscrabble 1940s, this prestige beauty industry legend surveys the world’s current travails and sees opportunity.

With the OECD from 2012 to 2022, Pascal Saint-Amans electrified tax policy discussions and crafted the global minimum corporate tax and other reforms that will have a profound effect on the global economy in coming…

Anti-aging research is accelerating, with profound implications for society. By Ben Hirschler.